Lucid Diagnostics (LUCD) EBITDA Margin Growth (3y) (2024 - 2026)
Powered by 
Analysis
Lucid Diagnostics (LUCD) EBITDA Margin Growth (3y) (2024 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 47.08 Bn | 45.98 Bn | 486.15 Mn | 3,294.00 |
| 2 | Labcorp Holdings | 26.13 Bn | 25.99 Bn | 1.11 Bn | 333.00 |
| 3 | Quest Diagnostics | 25.90 Bn | 25.27 Bn | 1.03 Bn | 20.00 |
| 4 | Guardant Health | 21.89 Bn | 20.84 Bn | 219.03 Mn | 4,867.00 |
| 5 | Tempus AI | 11.21 Bn | 10.39 Bn | 274.25 Mn | 1,424.00 |
| 6 | Caris Life Sciences | 6.94 Bn | 6.15 Bn | 182.38 Mn | - |
| 7 | Sotera Health | 5.22 Bn | 4.86 Bn | 177.96 Mn | 941.00 |
| 8 | BillionToOne | 4.78 Bn | 4.23 Bn | 77.11 Mn | - |
| 9 | iRhythm Holdings | 3.96 Bn | 3.37 Bn | 163.21 Mn | 1,407.00 |
| 10 | Lucid Diagnostics | 155.47 Mn | 122.07 Mn | 55,000.00 | 643,213.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 643,213.00 |
| Mar 31, 2026 | 227,824.00 |
| Dec 31, 2025 | 1.24 Mn |
| Sep 30, 2025 | 1.79 Mn |
| Mar 31, 2025 | 498,450.00 |
| Dec 31, 2024 | 271,317.00 |
| Sep 30, 2024 | 225,722.00 |